献血者铁缺乏研究进展*

doi:10.3969/j.issn.1671-2587.2023.05.021

临床输血与检验 ›› 2023, Vol. 25 ›› Issue (5): 699-705.DOI: 10.3969/j.issn.1671-2587.2023.05.021

献血者铁缺乏研究进展^*

李波¹, 曾祥龙²

¹中国人民解放军联勤保障部队第九二五医院输血医学科,贵州贵阳 550009;
²中国人民解放军西藏军区总医院,西藏拉萨 850007

收稿日期:2023-06-19 出版日期:2023-10-20 发布日期:2023-11-20
通讯作者: 曾祥龙,主要从事营养与疾病方面研究,（E-mai）quollzxl66@foxmail.com。
作者简介:李波,主要从事输血医学方面研究,（E-mail）lbshyfz@aliyun.com。

Research Progress in Iron Deficiency among Blood Donors

LI Bo, ZENG Xianglong

Department of Blood Transfusion,925th Hospital of PLA Joint Logistics Support Force,Guiyang 550009

Received:2023-06-19 Online:2023-10-20 Published:2023-11-20

摘要/Abstract

摘要： 献血者及其捐献的各种血液成分,是保障医疗服务的关键。每次献血（尤其是捐献全血）均会丢失部分铁储备,两次献血之间,若铁摄入不足或是献血间隔时间不够,因重复献血导致的铁丢失会逐渐累积,进而出现铁缺乏,甚至贫血。此外,铁缺乏还可能影响献血者的健康,产生诸如疲劳、认知能力改变等症状,阻碍献血者坚持长期献血。为及时发现并预防献血者的铁缺乏,采供血机构可采取多种应对措施,包括及时调整献血者的献血间隔和频率,检测铁营养状况和补铁疗法等。本文将对献血者铁缺乏研究进展做一综述。

关键词: 献血, 铁缺乏, 铁蛋白检测, 献血间隔, 补铁

Abstract: Blood donors and the blood components they willingly provide play a key role in the healthcare system service in all over the world. As a result of one donation, particularly whole blood donors will loss part of their total iron stores. The cumulative effect of repeat blood donations without sufficient iron replacement or a longer interval between donations results in iron deficiency (ID) in many donors, even anemia in some. Moreover, ID can be associated with side effects that can impact a blood donor's health, such as fatigue, cognitive changes and other factors, that may prevent the donors from maintaining long-term blood donation. In an effort to better identify and prevent ID, blood collection agencies are recommending various strategies, including changes in the donation interval, donation frequency, testing of iron status and iron supplementation. This review summarizes the progress in related research area.

Key words: Blood donor, Iron deficiency, Ferritin measurement, Interdonation interval, Iron supplement

中图分类号:

R457

李波, 曾祥龙. 献血者铁缺乏研究进展^*[J]. 临床输血与检验, 2023, 25(5): 699-705.

LI Bo, ZENG Xianglong. Research Progress in Iron Deficiency among Blood Donors[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(5): 699-705.

参考文献

[1] GBD 2016 Disease and Injury Incidence and Prevalence Collaborators.Global,regional,and national incidence,prevalence,and years lived with disability for 328 diseases and injuries for 195 countries,1990-2016:a systematic analysis for the Global Burden of Disease Study 2016BD 2016 Disease and Injury Incidence and Prevalence Collaborators.Global,regional,and national incidence,prevalence,and years lived with disability for 328 diseases and injuries for 195 countries,1990-2016:a systematic analysis for the Global Burden of Disease Study 2016[J].Lancet,2017,390(10100):1211-1259.
[2] WHO.Global nutrition targets2025: anaemia policy brief (WHO/NMH/NHD/14.4).Geneva: World Health Organization; 2014.[EB/OL].https://www.who.int/publications/i/item/WHO-NMH-NHD-14.4.
[3] CABLE R G,GLYNN S A,KISS J E,et al.Iron deficiency in blood donors:the REDS-II Donor Iron Status Evaluation (RISE) study[J].Transfusion,2012,52(4):702-711.
[4] RIGAS A S,SORENSEN C J,PEDERSEN O B,et al.Predictors of iron levels in 14,737 Danish blood donors:results from the Danish Blood Donor Study[J].Transfusion,2014,54(3 Pt 2):789-796.
[5] KISS J E,VASSALLO R R.How do we manage iron deficiency after blood donation?[J].Br J Haematol,2018,181(5):590-603.
[6] GOLDMAN M,MAGNUSSEN K,GORLIN J,et al.International Forum regarding practices related to donor haemoglobin and iron[J].Vox Sang,2016,111(4):449-455.
[7] 王雪珩,邱艳,郑鸿尘,等.献血人群铁缺乏影响因素及干预措施的研究进展[J].中华流行病学杂志,2022,43(3):440-444.
[8] BIANCO C,BRITTENHAM G,GILCHER R O,et al.Maintaining iron balance in women blood donors of childbearing age:summary of a workshop[J].Transfusion,2002,42(6):798-805.
[9] NEWMAN B.Iron depletion by whole-blood donation harms menstruating females:the current whole-blood-collection paradigm needs to be changed[J].Transfusion,2006,46(10):1667-1681.
[10] KISS J E,BIRCH R J,STEELE W R,et al.Quantification of body iron and iron absorption in the REDS-II Donor Iron Status Evaluation (RISE) study[J].Transfusion,2017,57(7):1656-1664.
[11] HELMER O M,EMERSON C P.The iron content of the whole blood of normal individuals[J].J Biol Chem,1934,104(1):157-161.
[12] DI ANGELANTONIO E,THOMPSON S G,KAPTOGE S,et al.Efficiency and safety of varying the frequency of whole blood donation (INTERVAL):a randomised trial of 45000 donors[J].Lancet,2017,390(10110):2360-2371.
[13] 郭瑾,施欣,王瑞,等.北京地区全血献血者铁蛋白调查分析[J].中国输血杂志,2021,34(1):4-7.
[14] GARRY P,KOEHLER K,SIMON T.Iron stores and iron absorption:effects of repeated blood donations[J].Am J Clin Nutr,1995,62(3):611-620.
[15] GIRELLI D,NEMETH E,SWINKELS D W.Hepcidin in the diagnosis of iron disorders[J].Blood,2016,127(23):
2809-2813.
[16] HUTCHINSON C,GEISSLER C A,POWELL J J,et al.Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis[J].Gut,2007,56(9):1291-1295.
[17] BIALKOWSKI W,KISS J E,WRIGHT D J,et al.Estimates of total body iron indicate 19 Mg and 38 Mg oral iron are equivalent for the mitigation of iron deficiency in individuals experiencing repeated phlebotomy[J].Am J Hematol,2017,92(9):851-857.
[18] MORETTI D,GOEDE J S,ZEDER C,et al.Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women[J].Blood,2015,126(17):1981-1989.
[19] MORETTI D,GOEDE J S,ZEDER C,et al.Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women[J].Blood,2015,126(17):1981-1989.
[20] SCHRIER S L.So You know how to treat iron deficiency anemia[J].Blood,2015,126(17):1971.
[21] TOLKIEN Z,STECHER L,MANDER A P,et al.Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults:a systematic review and meta-analysis[J].PLoS One,2015,10(2):e0117383.
[22] INABA S,TAKANASHI M,MATSUZAKI K,et al.Analysis of a questionnaire on adverse reactions to blood donation in Japan[J].Transfus Apher Sci,2013,48(1):21-34.
[23] AABB.AABB donor iron deficiency risk-based decision-making assessment report supplemental material.[EB/OL].https://www.aabb.org/tm/Documents/AABB-Donor-Iron-Deficiency RBDM-Assessment-Report-Supplemental-Material.pdf.
[24] VASSALLO R R.Donor iron depletion:beneficial or burdensome?[J].Transfusion,2019,59(7):2184-2186.
[25] MOORE C,BOLTON T,WALKER M,et al.Recruitment and representativeness of blood donors in the INTERVAL randomised trial assessing varying inter-donation intervals[J].Trials,2016,17(1):458.
[26] HOD E A,BRITTENHAM G M,BITAN Z C,et al.A randomized trial of blood donor iron repletion on red cell quality for transfusion and donor cognition and well-being[J].Blood,2022,140(25):2730-2739.
[27] ALEXANDER H D,SHERLOCK J P,BHARUCHA C.Red cell indices as predictors of iron depletion in blood donors[J].Clin Lab Haematol,2000,22(5):253-258.
[28] CABLE R G,STEELE W R,MELMED R S,et al.The difference between fingerstick and venous hemoglobin and hematocrit varies by sex and iron stores[J].Transfusion,2012,52(5):1031-1040.
[29] BAART A M,VAN NOORD P A H,VERGOUWE Y,et al.High prevalence of subclinical iron deficiency in whole blood donors not deferred for low hemoglobin[J].Transfusion,2013,53(8):1670-1677.
[30] RADTKE H,MEYER T,KALUS U,et al.Rapid identification of iron deficiency in blood donors with red cell indexes provided by Advia 120[J].Transfusion,2005,45(1):5-10.
[31] KISS J E,STEELE W R,WRIGHT D J,et al.Laboratory variables for assessing iron deficiency in REDS-II Iron Status Evaluation (RISE) blood donors[J].Transfusion,2013,53(11):2766-2775.
[32] KISS J E,BRAMBILLA D,GLYNN S A,et al.Oral iron supplementation after blood donation:a randomized clinical trial[J].JAMA,2015,313(6):575-583.
[33] DIJKSTRA A,VAN DEN HURK K,BILO H J G,et al.Repeat whole blood donors with a ferritin level of 30 μg/L or less show functional iron depletion[J].Transfusion,2019,59(1):21-25.
[34] WHO.WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations[M].Geneva: World Health Organization; 2020.
[35] HALLBERG L,BENGTSSON C,LAPIDUS L,et al.Screening for iron deficiency:an analysis based on bone-marrow examinations and serum ferritin determinations in a population sample of women[J].Br J Haematol,1993,85(4):787-798.
[36] MAST A E,BIALKOWSKI W,BRYANT B J,et al.A randomized,blinded,placebo-controlled trial of education and iron supplementation for mitigation of iron deficiency in regular blood donors[J].Transfusion,2016,56(6pt2):1588-1597.
[37] PASRICHA S R,MARKS D C,SALVIN H,et al.Postdonation iron replacement for maintaining iron stores in female whole blood donors in routine donor practice:results of two feasibility studies in Australia[J].Transfusion,2017,57(8):1922-1929.
[38] AABB.Standards for Blood Banks and Transfusion Services, 30th edn[S].2016.
[39] AABB.AABB Association Bulletin #17-02: updated strategies to limit or prevent iron deficiency in blood donors[EB/OL].http://www.aabb.org/programs/publications/bulletins/Docs/ab17-02.pdf.
[40] JPAC.Guidelines for the Blood Transfusion Services in the UK(8th Edition)[EB/OL].https://www.transfusionguidelines.org/red-book.
[41] SWEEGERS M,ZALPURI S,QUEE F,et al.Ferritin measurement IN Donors—effectiveness of iron Monitoring to diminish iron deficiency and low haemoglobin in whole blood donors (FIND'EM):study protocol for a stepped wedge cluster randomised trial[J].Trials, 2020,21(1):823.
[42] GOLDMAN M,UZICANIN S,OSMOND L,et al.Two-year follow-up of donors in a large national study of ferritin testing[J].Transfusion,2018,58(12):2868-2873.
[43] GOLDMAN M,UZICANIN S,OSMOND L,et al.A large national study of ferritin testing in Canadian blood donors[J].Transfusion,2017,57(3):564-570.
[44] CABLE R G,BRAMBILLA D,GLYNN S A,et al.Effect of iron supplementation on iron stores and total body iron after whole blood donation[J].Transfusion,2016,56(8):2005-2012.
[45] SCHOTTEN N,PASKER-DE JONG P C M,MORETTI D,et al.The donation interval of 56 days requires extension to 180 days for whole blood donors to recover from changes in iron metabolism[J].Blood,2016,128(17):2185-2188.
[46] CABLE R G,BIRCH R J,SPENCER B R,et al.The operational implications of donor behaviors following enrollment in STRIDE (Strategies to Reduce Iron Deficiency in blood donors)[J].Transfusion,2017,57(10):2440-2448.
[47] 马维娟,王同显,马保凤.献血相关性铁缺乏及其应对策略[J].中国输血杂志,2017,30(11):1307-1311.
[48] PASRICHA S R,TYE-DIN J,MUCKENTHALER M U,et al.Iron deficiency[J].Lancet,2021,397(10270):233-248.
[49] TRUMBO P,YATES A A,SCHLICKER S,et al.Dietary reference intakes:vitamin A,vitamin K,arsenic,boron,chromium,copper,iodine,iron,manganese,molybdenum,nickel,silicon,vanadium,and zinc[J].J Am Diet Assoc,2001,101(3):294-301.
[50] SPENCER B R,JOHNSON B,WRIGHT D J,et al.Potenti al impact on blood availability and donor iron status of changes to donor hemoglobin cutoff and interdonation intervals[J].Transfusion,2016,56(8):1994-2004.
[51] GOLDMAN M,STEELE W R,DI ANGELANTONIO E,et al.Comparison of donor and general population demographics over time:a BEST Collaborative group study[J].Transfusion,2017,57(10):2469-2476.
[52] JAHANSHAD N,KOHANNIM O,HIBAR D P,et al.Brain structure in healthy adults is related to serum transferrin and the H63D polymorphism in the HFE gene[J].Proc Natl Acad Sci U S A,2012,109(14): E851-E859.
[53] GOGTAY N,GIEDD J N,LUSK L,et al.Dynamic mapping of human cortical development during childhood through early adulthood[J].Proc Natl Acad Sci USA,2004,101(21):8174-8179.
[54] 李玲,王金花,邵雷,等.2018年江苏地区全血献血者铁营养状况调查[J].中国输血杂志,2020,33(9):950-952.
[55] 李晓瑜,李艳平,王竹天,等.食品中不同铁强化措施的安全性研究[J].中国食品卫生杂志,2010,22(4):293-299.

献血者铁缺乏研究进展^*

Research Progress in Iron Deficiency among Blood Donors

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

关于本刊

作者中心

在线期刊

访问统计

联系我们

[1]	华敏玉, 丁月平, 王振兴, 李丽, 赵冬梅, 刘伟, 严婷婷, 温珊, 沈有华, 朱丽莉, 赵兰青, 杨崇, 胡秀兰, 胡官林, 任素玲, 史亚平, 潘阳春, 徐爱华, 高宏, 张涵雪, 夏晶晶, 王文志, 范丽莉, 马学超, 邱艳. 新冠疫情对我国地市级血站单采血小板采集供应的影响[J]. 临床输血与检验, 2023, 25(5): 641-647.
[2]	钟馨, 邱浩川, 陈斯亮, 李朝晖, 毛怀东, 章俊. 低血红蛋白密度对血液透析贫血患者缺铁性贫血和铁缺乏的诊断价值分析^*[J]. 临床输血与检验, 2023, 25(5): 654-661.
[3]	胡婷婷, 邹彬彬, 赵飞雪. 长沙地区无偿献血者输血传播HIV残余风险评估[J]. 临床输血与检验, 2023, 25(4): 509-513.
[4]	赵冬雁, 沈有华, 田志彬, 项征国, 李涛, 张微, 张国权, 李玲, 徐今晶, 薛双林, 张丹, 王晓颖, 袁晓华, 侯玲华, 马立仙, 段志倩, 李丽, 贾红志, 赵兰青, 王振兴, 范丽莉, 张珩, 张秀琪, 程念念, 赵超, 邱艳. 全血献血人群和单采献血人群延迟献血因素的对比分析研究[J]. 临床输血与检验, 2023, 25(3): 388-395.
[5]	胡一帆, 黄丽萍, 刘义全. 应用视频刺激试验预防焦虑引起献血相关迷走神经反应的效果观察^*[J]. 临床输血与检验, 2023, 25(2): 230-234.
[6]	谢东甫, 黄霞, 杨俊鸿, 孙洁, 张晰, 何涛. 国内外血液安全监测报告若干数据指标的比较与分析^*[J]. 临床输血与检验, 2023, 25(1): 16-20.
[7]	杨俊鸿, 胡文杰, 杨培, 邓莉, 黄霞, 徐永柱. 某血液中心开展献血不良反应监测实践及效果评价^*[J]. 临床输血与检验, 2023, 25(1): 21-25.
[8]	朱文钦, 陈齐, 曾嘉, 黄霞. 福州地区全血献血不良反应哨点监测情况分析[J]. 临床输血与检验, 2023, 25(1): 26-32.
[9]	李鹏, 袁玉荣, 张敏, 曾怡, 卢伟, 张莉, 黄霞. 献血相关血管迷走神经反应献血者血浆ET-1、NO检测和分析^*[J]. 临床输血与检验, 2023, 25(1): 44-47.
[10]	李婉, 王娅, 肖光林, 陈勇军. 成分献血与骨代谢及骨密度相关性研究进展^*[J]. 临床输血与检验, 2023, 25(1): 143-148.
[11]	陈晓莉, 冯雅颂, 朱瑞, 蒋昵真. 南京地区无偿献血者戊型肝炎病毒筛查策略探讨^*[J]. 临床输血与检验, 2022, 24(6): 759-762.
[12]	宋英伟, 卞成蓉, 潘雪, 张晓娟, 冯丽梅, 张宏飞, 宋丽娟, 汪德清. 多次捐献单采血小板对男性献血者白细胞与血小板相关参数的影响研究^*[J]. 临床输血与检验, 2022, 24(5): 610-614.
[13]	谢君谋, 廖芬芳, 王淏, 杜荣松, 高文博, 郑优荣, 李仲平. 2例重复献血者HIV血清学检测窗口期追踪结果分析^*[J]. 临床输血与检验, 2022, 24(5): 647-650.
[14]	杨剑豪, 徐蓓, 邱颖婕, 章舜玮, 周燕, 何智纯. 现用手臂皮肤碘伏消毒方式对不同献血人群消毒效果的研究[J]. 临床输血与检验, 2022, 24(4): 459-463.
[15]	王翠娥, 孔长虹, 徐烨彪, 裘君娜, 金立明, 胡伟. 浙江省献血者与献浆者间隔期信息共享系统的建立与应用^*[J]. 临床输血与检验, 2021, 23(6): 719-722.